San Yuan Biology: Shareholder Lu Xin Capital has reduced its holdings by nearly 6 million shares, and its stake has decreased to 0.97%.

San Yuan Bios announcement that the shareholder Lu Xin Capital's reduction plan has expired. The original plan was to reduce a total of no more than 6 million shares, or 3% of the total share capital excluding repurchased shares, through centralized bidding and block trading starting from a specific time in 2025. As of the announcement date, Lu Xin Capital reduced 4 million shares through block trading from August 7 to October 29, reduced 1,990,050 shares through centralized bidding, totaling 5,990,050 shares, accounting for 2.995%. After the reduction, Lu Xin Capital's shareholding decreased to 1.93 million shares, accounting for 0.97% of the total share capital. This reduction did not lead to a change in control of the company and had no significant impact on the company's operations.